Overview
Hetalox is a company that offers artificial intelligence (AI) solutions for the advanced assessment and analysis of brain MRI studies, specifically aimed at monitoring the progression of neurodegenerative and demyelinating diseases such as dementia and multiple sclerosis. Their services include early disease detection, monitoring disease progression, and supporting treatment decisions to improve patient quality of life.
Financials
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Hetalox Secures 2nd Place at the MIT GSW 2025 Pitching Competition!
We assist in monitoring the progression of neurodegenerative and demyelinating diseases. We offer artificial intelligence (AI) solutions for advanced assessment and analysis of brain MRI studies.
Hetalox specialization and why it matters
At Hetalox, we specialize in the early detection and in-depth analysis of brain atrophy using advanced AI-driven MRI analysis.
We begin acceleration in the Startup Booster for Social Impact program
In cooperation with 24ventures fund and mentors we are going to conduct pilot studies that will verify the effectiveness of the platform in clinical conditions and more.
Hetalox at the 6th Saxon-Polish Innovation Day
We were honored to participate in the 6th Saxon-Polish Days, where Hetalox was proudly represented by our team
Made in Wrocław 2024 - Hetalox participation in the event
Hetalox participated in VC Demo Day during the Made in Wrocław 2024 event, showcasing our AI-driven solutions for medical imaging.
Our workshop at MICCAI 2024
We had an incredible time at the MICCAI 2024 Conference during the CLINICCAI (Clinical Translation of Medical Image Computing and Computer-Assisted Interventions), where we had the pleasure to present the work with significant contributions from Hetalox.
Industry
Bank accounts
Registered as a VAT taxpayer on 2024-02-01. Active
60 1140 2004 0000 3102 8444 9794
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 18, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $100.4K$100,448 | Uniwersytet SWPS |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Kazimierz Konopczyński (37) | 436 | $5,888.71 | 54.5% |
Adrian Korbecki (34) | 364 | $4,916.26 | 45.5% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Tomasz Kazimierz Konopczyński (37)  | Shareholder of a limited liability company, 21800.0 PLN | |
Adrian Korbecki (34) | Shareholder of a limited liability company, 18200.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Dentioscansp. z o.o. | $118.24 | dentioscan.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-06-24 | Share capital change (5,000.00 PLN → 40,000.00 PLN) | |
| 2024-01-05 | Entered in the register |
FAQ
Last updated: 2026-06-19